You are here

Article Text

Article menu
Download PDFPDF
PostScript
Letter
British Society of Gastroenterology guidelines on the diagnosis and management of coeliac disease
  1. Peter Hill1,
  2. Andrew Austin2,
  3. Julia Forsyth3,
  4. Geoffrey Holmes4
  1. 1 Emeritus Consultant Clinical Biochemist, Royal Derby Hospital, Derby, Derbyshire, UK
  2. 2 Derby Digestive Diseases Centre, Royal Derby Hospital, Derby, UK
  3. 3 Department of Clinical Biochemistry, Royal Derby Hospital, Derby, Derbyshire, UK
  4. 4 Emeritus Consultant Gastroenterologist, Royal Derby Hospital, Derby, UK
  1. Correspondence to Dr Andrew Austin, Derby Digestive Diseases Centre, Royal Derby Hospital, Derby, UK; andrew.austin1{at}nhs.net

https://doi.org/10.1136/gutjnl-2014-308420

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    The British Society of Gastroenterology (BSG) guidelines1 on diagnosis and management of coeliac disease (CD) contain much useful information, but in our opinion are badly misleading on the important topic of diagnosis and the relative merits of small intestinal biopsy and serology tests. The authors recommend that a duodenal biopsy is essential for diagnosis in all patients and cannot be replaced by serology alone even in a subset of patients.

    Other studies have now confirmed earlier work showing that using an appropriate cut-off for IgA-class anti-tissue transglutaminase antibody (IgA-tTG), the diagnosis can be made with a positive predictive value …

    View Full Text

    Footnotes

    • Contributors All authors contributed to the content of this letter.

    • Competing interests None.

    • Provenance and peer review Not commissioned; internally peer reviewed.

    Linked Articles